Pancreatic Carcinoma — Trials

Pancreatic Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,382 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 489
Recruiting: 282
Ph III recruiting: 29
Growth YoY: +27.7%
Industry share: 36%
Top sponsor: National Cancer Institute (NCI)
Termination share: 37.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (201)

clinicaltrialsPublishedShowing 101–131 of 131 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03740256	Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors(VISTA)	recruiting	Phase 1	45	Baylor College of MedicineOTHER	1	Feb 6, 2026	clinicaltrials
NCT07030283	Intraperitoneal Paclitaxel With NALIRIFOX for Pancreatic Ductal Adenocarcinoma With Peritoneal Carcinomatosis	recruiting	Phase 1	10	University of Colorado, DenverOTHER	1	Feb 2, 2026